Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

177 Views

Poster Session: Respiratory Infections - Viral

2189 - Anti-inflammatory Activity of Lefamulin in a Mouse Model of Influenza Virus H1N1 Infection

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

WW

Wolfgang W. Wicha, MSc

VP Pharmacokinetics & Pharmacodynamics
Nabriva Therapeutics GmbH
Vienna, Wien, Austria
SK

Sandy Kimber, PhD

Charles River Discovery
Portishead, England, United Kingdom
CC

Charlotte Cumper, BSc

Charles River Discovery Services
Portishead, England, United Kingdom
HL

Hon S. Lam, MSc

Charles River Discovery Services
Portishead, England, United Kingdom
LB

Lorena S. Ballesteros, MSc

Charles River Discovery Services
Portishead, England, United Kingdom
CK

Christopher Kirkham, PhD

Charles River Discovery Services
Portishead, England, United Kingdom
CR

Claire Richards, PhD

Charles River Discovery Services
Portishead, England, United Kingdom

Presenting Author(s)

Steven P. Gelone, PharmD

President & Chief Operating Officer
Nabriva Therapeutics
Fort Washington, Pennsylvania, United States

Co-Author(s)

SP

Susanne Paukner, PhD

Vice President Microbiology
Nabriva Therapeutics
Vienna, Wien, Austria